Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ozgen Ozer"'
Autor:
Gokselin Ozgen, Merve Turk Gezer, Guliz Armagan, Petek Ballar Kirmizibayrak, Ayfer Yalcin, Ozgen Ozer, Banu Ozkirim Arslan, Gonul Kayar, Udaya Kumar Dude, Aysegul Kaymak Ozdemir
Publikováno v:
ACS Omega, Vol 9, Iss 16, Pp 18366-18374 (2024)
Externí odkaz:
https://doaj.org/article/03a6f904365a4f3f8e2bab07dd9c9034
Autor:
Manuela Donalisio, Federica Leone, Andrea Civra, Rita Spagnolo, Ozgen Ozer, David Lembo, Roberta Cavalli
Publikováno v:
Pharmaceutics, Vol 10, Iss 2, p 46 (2018)
Acyclovir is not a good candidate for passive permeation since its polarity and solubility limit is partitioning into the stratum corneum. This work aims to develop a new topical formulation for the acyclovir delivery. New chitosan nanospheres (NS) w
Externí odkaz:
https://doaj.org/article/8ee34a8164664f3285f7174c9d8f1882
Publikováno v:
Drug delivery and translational research. 12(2)
Dissolving microneedle (MN) patches are usually formulated with a blend of drug and excipients added for mechanical strength and drug stabilization. In this study, we developed MNs made of pure drug to maximize drug loading capacity. MN patches were
Autor:
Gulten Kantarci, Ozgen Ozer
Publikováno v:
Colloids in Biotechnology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a4871c2b4000689f9148f584abc6172
https://doi.org/10.1201/ebk1439830802-16
https://doi.org/10.1201/ebk1439830802-16
In Vivo Assessment of Clobetasol Propionate-Loaded Lecithin-Chitosan Nanoparticles for Skin Delivery
Autor:
Taner Şenyiğit, Fabio Sonvico, Alessandra Rossi, Işıl Tekmen, Patrizia Santi, Paolo Colombo, Sara Nicoli, Özgen Özer
Publikováno v:
International Journal of Molecular Sciences, Vol 18, Iss 1, p 32 (2016)
The aim of this work was to assess in vivo the anti-inflammatory efficacy and tolerability of clobetasol propionate (CP) loaded lecithin/chitosan nanoparticles incorporated into chitosan gel for topical application (CP 0.005%). As a comparison, a com
Externí odkaz:
https://doaj.org/article/c58df855315c4a55a63f355642fc7c2f